Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

dextromethorphan + bupropion in phase III trials

Posted by TriedEveryMedication on September 1, 2017, at 20:49:54

The company looking to market this is claiming this combo has all these traits

-NMDA Receptor Antagonist
-Sigma-1R Agonist
-Norepinephrine Reuptake Inhibitor
-Serotonin Reuptake Inhibitor
-Dopamine Reuptake Inhibitor
-Nicotinic ACh Receptor Antagonist

The bup decreases the metabolism of the DXM, like the quinidine in nuedexta does.

Stephen Stahl also claims DXM hit the mu-opioid receptor which is a little concerning.

What do you think? Anyone take DXM for depression?


a document on this is here: http://phx.corporate-ir.net/External.File?t=1&item=VHlwZT0yfFBhcmVudElEPTUyMzA2ODR8Q2hpbGRJRD02NDAwNzk=

Share
Tweet  

Thread

 

Post a new follow-up

Your message only Include above post

Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in
This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:TriedEveryMedication thread:1094813
URL: http://www.dr-bob.org/babble/20161215/msgs/1094813.html